Publications by authors named "A I Glukhova"

The P2X1 receptor is a trimeric ligand-gated ion channel that plays an important role in urogenital and immune functions, offering the potential for new drug treatments. However, progress in this area has been hindered by limited structural information and a lack of well-characterised tool compounds. In this study, we employ cryogenic electron microscopy (cryo-EM) to elucidate the structures of the P2X1 receptor in an ATP-bound desensitised state and an NF449-bound closed state.

View Article and Find Full Text PDF

Structural studies require the production of target proteins in large quantities and with a high degree of purity. For membrane proteins, the bottleneck in determining their structure is the extraction of the target protein from the cell membranes. A detergent that improperly mimics the hydrophobic environment of the protein of interest can also significantly alter its structure.

View Article and Find Full Text PDF

Comparison of acute pain syndrome after septoplasty, rhinoplasty, and rhinoseptoplasty was carried out. It is shown that the intensity of acute pain is higher in patients after rhinoseptoplasty in the first 3-6 h after surgery.

View Article and Find Full Text PDF

The necroptosis pathway is a lytic, pro-inflammatory mode of cell death that is widely implicated in human disease, including renal, pulmonary, gut and skin inflammatory pathologies. The precise mechanism of the terminal steps in the pathway, where the RIPK3 kinase phosphorylates and triggers a conformation change and oligomerization of the terminal pathway effector, MLKL, are only emerging. Here, we structurally identify RIPK3-mediated phosphorylation of the human MLKL activation loop as a cue for MLKL pseudokinase domain dimerization.

View Article and Find Full Text PDF
Article Synopsis
  • - The M muscarinic acetylcholine receptor (M mAChR) is a key target for drug development due to its role in managing psychosis, cognition, and addiction, with xanomeline showing promise in improving symptoms of schizophrenia in clinical trials.
  • - Recent research revealed the cryo-EM structure of xanomeline bound to the M mAChR, showing that two xanomeline molecules can simultaneously bind to different sites on the receptor.
  • - These findings suggest that xanomeline functions as both an orthosteric and allosteric ligand, enhancing our understanding of its complex pharmacology and how ligands can interact with GPCRs for therapeutic purposes.
View Article and Find Full Text PDF